Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human CD30: structural implications from epitope mapping and modeling studies.

Liying Dong1, Martin Hülsmeyer, Horst Dürkop

  • 1Institut für Medizinische Immunologie, Universitätsklinikum Charité, Humboldt-Universität zu Berlin, Berlin, Germany.

Journal of Molecular Recognition : JMR
|January 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Reply.

Deutsches Arzteblatt international·2026
Same author

Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants.

International journal of molecular sciences·2026
Same author

The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single <i>SMN2</i> copy: an international retrospective observational study.

EClinicalMedicine·2026
Same author

Urinary Metabolomics Predict Acute Kidney Injury in Very-Low-Birth-Weight Infants with Patent Ductus Arteriosus.

Biomolecules·2026
Same author

Confidence Intervals for Comparing Two Independent Folded Normals: A Case Study in Bunion Surgery.

Statistics in medicine·2026
Same author

Emulated Effects of Glucagon-Like Peptide 1 Receptor Agonist Therapy in the General Population.

Journal of the American College of Cardiology·2026

CD30, a molecule upregulated on tumor cells like Hodgkin and Reed-Sternberg cells, was studied to map its epitopes. Understanding these CD30 epitopes aids in developing targeted immunotherapies and diagnostic tools.

Area of Science:

  • Immunology
  • Molecular Biology
  • Structural Biology

Background:

  • The CD30 molecule is a diagnostic marker and potential immunotherapy target due to its specific upregulation on tumor cells, such as Hodgkin and Reed-Sternberg (H-RS) cells.
  • Mapping CD30 epitopes is crucial for designing effective anti-CD30 reagents for cancer therapy and diagnostics.

Purpose of the Study:

  • To map the specific epitopes recognized by various monoclonal antibodies (mAbs) and a single-chain Fv fragment against the human CD30 molecule.
  • To elucidate the structural organization of CD30 and its extracellular domain.

Main Methods:

  • Utilized a peptide array approach with overlapping CD30-derived peptides to identify antibody binding sites.
  • Employed molecular modeling to visualize epitope locations on the CD30 structure.

Related Experiment Videos

Main Results:

  • Identified linear epitopes for mAbs Ber-H2, Ki-2, and the R4-4 fragment.
  • Discovered a discontinuous epitope for mAb Ki-1, spanning two distinct regions of the CD30 molecule.
  • Molecular modeling localized epitopes to exposed loop regions within the N-terminal domain of CD30.

Conclusions:

  • The epitope mapping provides critical information for the development of novel anti-CD30 immunotherapies and diagnostic agents.
  • The findings suggest a flower-like structure for the homotrimeric CD30 molecule, with its N- and C-terminal extracellular regions in close proximity.